Table 1.
Overview of patient- and operation-specific factors.
| Patient-Specific Factors | |
|---|---|
| Age | 20 to 84 years; average age 65.2 years |
| Gender | Male: n = 18 (49%) |
| Female: n = 19 (51%) | |
| ASA-Score | ASA I: n = 5 (13.5%) |
| ASA II: n = 18 (48.6%) | |
| ASA III: n = 12 (32.4%) | |
| ASA IV: n = 2 (5.4%) | |
| BMI | 14.5–37.7; average BMI at 25.4 |
| Nicotine use | Smoking history: |
| Yes: n = 24 (64.9%); No: n = 13 (35.1%) | |
| Smoking habit at the time of surgery: | |
| Yes: n = 15 (40.5%); No: n = 15 (59.4%) | |
| Pack years: Mean 31 PY; (2–98 PY) | |
| Surgery-specific factors | |
| Type of graft | Radialis graft: n = 26 (71.1%) |
| Fibula graft: n = 10 (26.3%) | |
| Anterolateral thigh (ALT) graft n = 1 (2.6%) | |
| Localization of the defect | Lower jaw: n = 12 (32.4%) |
| Upper jaw/palate: n = 7 (18.9%) | |
| Tongue: n = 5 (13.5%) | |
| Floor of mouth: n = 6 (16.2%) | |
| Lip: n = 1 (2.7%) | |
| Other/overarching localizations: n = 6 (16.2%) | |
| Type of defect | Sole reconstruction (condition following tumor excision 1): n = 5 (13.5%) |
| Squamous cell carcinoma: n = 26 (70.3%) | |
| Other tumor type 2: n = 2 (5.4%) | |
| Osteonecrosis of the jaw 3: n = 3 (8.1%) | |
| Keratocyst: n = 1 (2.7%) | |
| Tumor stage | No tumor: n = 9 (24.3%) |
| Stage 1: n = 6 (16.2%) | |
| Stage 2: n = 9 (24.3%) | |
| Stage 3: n = 6 (16.2%) | |
| Stage 4: n = 6 (16.2%) | |
| Recurrence: n = 1 (2.7%) | |
| Postoperative graft complications | Intraoral wound infection: n = 1 |
| Wound dehiscence: n = 1 4 | |
| Complete graft loss: n = 1 |
1 Mucoepidermoid carcinoma n = 1, fibrosarcoma n = 1, squamous cell carcinoma n = 1, radiation-induced sarcoma n = 1 and adenocystic carcinoma n = 1; 2 adenocarcinoma n = 1; myoepithelial carcinoma n = 1; 3 MRONJ n = 2; osteoradionecrosis n = 1; 4 exclusively extraoral.